Receptor Biologix's Series A Round

Receptor Biologix raised a round of funding on April 11, 2005.

Receptor BioLogix, Inc. is a biopharmaceutical company focused on the development and commercialization of a newly discovered class of protein therapeutics called Intron Fusion Proteins (IFP) to treat…

Articles about Receptor Biologix's Series A Round: